Good Lifestyle

The effectiveness of theVaccines against COVID-19 Reveal in real-world case numbers continue to fall, because more people receive their doses. Nevertheless, scientists pointed out thatRegular boosters Will probably be necessary to prevent virus variants from emerging and spreading in the future. But thanks to new technologies, there could be a major difference in your next Covid vaccine that can have additional benefits. Read it to see how your future clichés can work.

According to a press release from the Novavax vaccine producer on May 10, the first tests of a study conducted on animals found that their combinationCOVID-19 and influenza vaccine successfully produces an immune response. Preliminary conclusions could pave the way for future vaccines that will address the two seasonal pathogens with a single shot.

"Despite the low rate of the Covid-19 pandemic, the flu remains a significant risk for global public health and the need for multipurpose and more efficient vaccines is as important as ever, including against influenza"Grégoire Glenn, President of Research and Development in Novavax, said in a declaration. "We believe that this new candidate of combined vaccines ... could constitute a significant future tool in the long-term struggle against these two harmful respiratory viruses."

The study tested a combination of nanoflu, the company's seasonal influenza vaccine that has not yet been submitted to officials for approval and NVX-COV2373, the companyVVID-19 vaccine that researchers have recently judged about90% effective With regard to the virus in a phase three clinical trial in the United Kingdom, representatives of the United Kingdom of Novavax stated that the combined flu-flu vaccine trial will now be examined by peers, but that clinical trials. In humans "should start by the end of the year. "

"Combined vaccines of seasonal flu and combination COVID-19 will likely be essential to the fight against emerging Covid-19 variants", "Russell WilsonNanoflu's Executive Vice President and Chief Executive Officer for Novavax stated in the Society Declaration. "Millions of people are affected by the influenza each year in the United States, and despite our vaccination efforts, currently available influenza vaccines are only partially effective ... We expect this combined vaccine to help Check Covid-19 and flu disease. "

RELATED:Here is the closing of your state to be fully vaccinated, shows data.

Novavax is not alone working on a two in one. During an appearance on CNBCSafe April 14, CEO of ModernaStéphane Bantel revealed that his company hopes to targetTwo health concerns In the future with a reminder that combines Covid and flu vaccines. "What we are trying to do toModerna is actually trying to get an influenza vaccine In the clinic this year, then combine our influenza vaccine at our Covid vaccine, so you have to have a boost at your local CVS store ... Every year that would protect you with the variant concern against Covid and the strain Seasonal flu "he explained.

Bantel also added that he believed that Moderna can make very effective influenza vaccines that exceed the typical efficiency rate of the normal influenza vaccine from 30 to 60%. "We believe that we should be able to get a high-efficiency ignition vaccine combined in the same shot with variants of Covid - high efficiency so you can take a dose, then have a good winter," he has a good winter, "he declared.

And for more Covid news sent directly to your inbox,Sign up for our daily newsletter.

An expert emphasized that the convenience of the combination of annual doses could have a drastic effect onProtect the public Of two potentially fatal viruses. "It would obviously be very fun if we could giveA shot of influenza and Covid at a time As it would be difficult to say the clinically difference in these two things and they happen in the same season, "Dan Shirley, Medical Director of Infection Prevention with a Health Unit Health Element in Wisconsin, told a local subsidiary of the NBC.

But Shirley also pointed out that the development of Covid-19 vaccines represented a turning point in the way vaccinations were developed and produced, probably increasing the speed at which they reached the market in the future. "The other major advantage of mRNA technology, but also other vaccine technologies, is that we can do vaccines much faster," he added.

RELATED:Dr. Fauci says we will be "close to return to normal" by this exact date.